dihydroxyphenylalanine has been researched along with Cancer of the Thyroid in 37 studies
Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.
Excerpt | Relevance | Reference |
---|---|---|
"(18)F-fluorodihydroxyphenylalanine (FDOPA) is a powerful tool for the diagnosis and detection of neuroendocrine tumors when planning and monitoring surgical and oncologic therapies." | 8.90 | 18F-fluorodihydroxyphenylalanine in the diagnosis of neuroendocrine tumors. ( Forsback, S; Kauhanen, S; Kemppainen, J; Minn, H; Seppänen, M, 2014) |
"In recent years, 6-l-18F-fluorodihydroxyphenylalanine (18F-DOPA) PET has emerged as a new diagnostic tool for the imaging of neuroendocrine tumors." | 8.84 | 6-L-18F-fluorodihydroxyphenylalanine PET in neuroendocrine tumors: basic aspects and emerging clinical applications. ( Brouwers, AH; Chirakal, R; Gulenchyn, KY; Jager, PL; Koopmans, KP; Marriott, CJ, 2008) |
"(18)F-fluorodihydroxyphenylalanine (FDOPA) is a powerful tool for the diagnosis and detection of neuroendocrine tumors when planning and monitoring surgical and oncologic therapies." | 4.90 | 18F-fluorodihydroxyphenylalanine in the diagnosis of neuroendocrine tumors. ( Forsback, S; Kauhanen, S; Kemppainen, J; Minn, H; Seppänen, M, 2014) |
"In recent years, 6-l-18F-fluorodihydroxyphenylalanine (18F-DOPA) PET has emerged as a new diagnostic tool for the imaging of neuroendocrine tumors." | 4.84 | 6-L-18F-fluorodihydroxyphenylalanine PET in neuroendocrine tumors: basic aspects and emerging clinical applications. ( Brouwers, AH; Chirakal, R; Gulenchyn, KY; Jager, PL; Koopmans, KP; Marriott, CJ, 2008) |
"11 C-methionine was most sensitive in lung lesions." | 3.01 | Sensitivities evaluation of five radiopharmaceuticals in four common medullary thyroid carcinoma metastatic sites on PET/CT: a network meta-analysis and systematic review. ( Li, P; Wei, T; Xu, T; Zhang, Y; Zhao, W; Zhu, J, 2023) |
"Medullary thyroid cancer (MTC) is considered as a rare thyroid cancer." | 2.50 | 18F-DOPA and 18F-FDG PET/CT, scintigraphic localization and radioguided surgery of recurrent medullary thyroid cancer: two case reports. ( Evangelista, L; Farsad, M; Pelizzo, MR; Piotto, A, 2014) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (5.41) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (10.81) | 29.6817 |
2010's | 29 (78.38) | 24.3611 |
2020's | 2 (5.41) | 2.80 |
Authors | Studies |
---|---|
Li, P | 1 |
Zhang, Y | 1 |
Xu, T | 1 |
Zhu, J | 1 |
Wei, T | 1 |
Zhao, W | 1 |
Rotania, M | 1 |
Chabrier, G | 2 |
Imperiale, A | 4 |
Taralli, S | 1 |
Lorusso, M | 1 |
Capotosti, A | 1 |
Lanni, V | 1 |
Indovina, L | 1 |
Rufini, V | 5 |
Golubić, AT | 1 |
Pasini Nemir, E | 1 |
Žuvić, M | 1 |
Mutvar, A | 1 |
Kusačić Kuna, S | 1 |
Despot, M | 1 |
Samardžić, T | 1 |
Huić, D | 1 |
Rasul, S | 1 |
Hartenbach, S | 1 |
Rebhan, K | 1 |
Göllner, A | 1 |
Karanikas, G | 3 |
Mayerhoefer, M | 2 |
Mazal, P | 1 |
Hacker, M | 1 |
Hartenbach, M | 1 |
Brammen, L | 1 |
Niederle, MB | 1 |
Riss, P | 1 |
Scheuba, C | 1 |
Selberherr, A | 1 |
Bodner, G | 1 |
Koperek, O | 1 |
Niederle, B | 1 |
Terroir, M | 1 |
Grimaldi, S | 1 |
Hartl, D | 1 |
Leboulleux, S | 1 |
Deandreis, D | 1 |
Balogova, S | 2 |
Talbot, JN | 3 |
Nataf, V | 2 |
Michaud, L | 1 |
Huchet, V | 1 |
Kerrou, K | 2 |
Montravers, F | 3 |
Slavikova, K | 1 |
Treglia, G | 5 |
Kunikowska, J | 1 |
Kaliska, L | 1 |
Vereb, M | 1 |
Minn, H | 2 |
Kemppainen, J | 1 |
Kauhanen, S | 2 |
Forsback, S | 1 |
Seppänen, M | 2 |
Santhanam, P | 1 |
Taïeb, D | 2 |
Evangelista, L | 1 |
Farsad, M | 1 |
Piotto, A | 1 |
Pelizzo, MR | 2 |
Sesti, A | 1 |
Weber, M | 1 |
Anner, P | 1 |
Wadsak, W | 1 |
Dudczak, R | 1 |
Haug, A | 1 |
Shamim, SA | 1 |
Kumar, A | 1 |
Kumar, R | 1 |
Archier, A | 1 |
Heimburger, C | 1 |
Guerin, C | 1 |
Morange, I | 1 |
Palazzo, FF | 1 |
Henry, JF | 1 |
Schneegans, O | 2 |
Mundler, O | 1 |
Abdullah, AE | 1 |
Sebag, F | 1 |
Ruiz, JB | 1 |
Orré, M | 1 |
Cazeau, AL | 1 |
Henriques de Figueiredo, B | 1 |
Godbert, Y | 1 |
Beheshti, M | 1 |
Pöcher, S | 1 |
Vali, R | 1 |
Waldenberger, P | 1 |
Broinger, G | 1 |
Nader, M | 1 |
Kohlfürst, S | 1 |
Pirich, C | 1 |
Dralle, H | 2 |
Langsteger, W | 1 |
Pestourie, C | 1 |
Thézé, B | 1 |
Kuhnast, B | 1 |
Le Helleix, S | 1 |
Gombert, K | 1 |
Dollé, F | 1 |
Tavitian, B | 1 |
Ducongé, F | 1 |
Ambrosini, V | 4 |
Marzola, MC | 2 |
Rubello, D | 2 |
Fanti, S | 4 |
Ferdeghini, M | 1 |
Toniato, A | 1 |
Massaro, A | 1 |
Gross, MD | 1 |
Al-Nahhas, A | 1 |
Morel, O | 1 |
Giraud, P | 1 |
Cahouet, A | 1 |
Lacoeuille, F | 1 |
Girault, S | 1 |
Luster, M | 1 |
Karges, W | 1 |
Zeich, K | 1 |
Pauls, S | 1 |
Verburg, FA | 1 |
Glatting, G | 1 |
Buck, AK | 1 |
Solbach, C | 1 |
Neumaier, B | 1 |
Reske, SN | 1 |
Mottaghy, FM | 1 |
Greget, M | 1 |
Keomany, J | 1 |
Rust, E | 2 |
Detour, J | 1 |
Pessaux, P | 1 |
Goichot, B | 1 |
Walter, MA | 1 |
Benz, MR | 1 |
Hildebrandt, IJ | 1 |
Laing, RE | 1 |
Hartung, V | 1 |
Damoiseaux, RD | 1 |
Bockisch, A | 1 |
Phelps, ME | 1 |
Czernin, J | 1 |
Weber, WA | 1 |
Schalin-Jäntti, C | 1 |
Kajander, S | 1 |
Virtanen, S | 1 |
Schildt, J | 1 |
Lisinen, I | 1 |
Ahonen, A | 1 |
Heiskanen, I | 1 |
Väisänen, M | 1 |
Arola, J | 1 |
Korsoff, P | 1 |
Ebeling, T | 1 |
Sane, T | 1 |
Välimäki, MJ | 1 |
Nuutila, P | 1 |
Castaldi, P | 3 |
Villani, MF | 2 |
Perotti, G | 2 |
de Waure, C | 2 |
Filice, A | 2 |
Cremonini, N | 2 |
Santimaria, M | 1 |
Versari, A | 2 |
Giordano, A | 3 |
Soussan, M | 1 |
Grahek, D | 1 |
Pascal, O | 1 |
Boulanger, C | 1 |
Roedlich, MN | 1 |
Ollier, JC | 1 |
Cocciolillo, F | 1 |
Di Nardo, F | 1 |
Poscia, A | 1 |
Verbeek, HH | 1 |
Plukker, JT | 1 |
Koopmans, KP | 2 |
de Groot, JW | 1 |
Hofstra, RM | 1 |
Muller Kobold, AC | 1 |
van der Horst-Schrivers, AN | 1 |
Brouwers, AH | 2 |
Links, TP | 1 |
Beuthien-Baumann, B | 1 |
Strumpf, A | 1 |
Zessin, J | 1 |
Bredow, J | 1 |
Kotzerke, J | 1 |
Jager, PL | 1 |
Chirakal, R | 1 |
Marriott, CJ | 1 |
Gulenchyn, KY | 1 |
Hoegerle, S | 1 |
Altehoefer, C | 1 |
Ghanem, N | 1 |
Brink, I | 1 |
Moser, E | 1 |
Nitzsche, E | 1 |
Atkins, FL | 1 |
Beaven, MA | 1 |
Keiser, HR | 1 |
Beskid, M | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
The Use of Fluorodopa F 18 Positron Emission Tomography Combined With Computed Tomography in Congenital Hyperinsulinism and Insulinoma[NCT02021604] | Phase 1 | 250 participants (Anticipated) | Interventional | 2013-10-09 | Recruiting | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
10 reviews available for dihydroxyphenylalanine and Cancer of the Thyroid
Article | Year |
---|---|
Sensitivities evaluation of five radiopharmaceuticals in four common medullary thyroid carcinoma metastatic sites on PET/CT: a network meta-analysis and systematic review.
Topics: Dihydroxyphenylalanine; Humans; Methionine; Network Meta-Analysis; Positron Emission Tomography Comp | 2023 |
18F-fluorodihydroxyphenylalanine vs other radiopharmaceuticals for imaging neuroendocrine tumours according to their type.
Topics: 3-Iodobenzylguanidine; Bronchial Neoplasms; Carcinoma, Merkel Cell; Dihydroxyphenylalanine; Fluorode | 2013 |
What is currently the best radiopharmaceutical for the hybrid PET/CT detection of recurrent medullary thyroid carcinoma?
Topics: Amines; Blood Glucose; Bone and Bones; Carcinoma, Neuroendocrine; Dihydroxyphenylalanine; Fluorine R | 2013 |
18F-fluorodihydroxyphenylalanine in the diagnosis of neuroendocrine tumors.
Topics: Adrenal Gland Neoplasms; Carcinoma, Neuroendocrine; Dihydroxyphenylalanine; Humans; Intestinal Neopl | 2014 |
Role of (18) F-FDOPA PET/CT imaging in endocrinology.
Topics: Adrenal Gland Neoplasms; Carbidopa; Carcinoid Tumor; Carcinoma, Neuroendocrine; Dihydroxyphenylalani | 2014 |
18F-DOPA and 18F-FDG PET/CT, scintigraphic localization and radioguided surgery of recurrent medullary thyroid cancer: two case reports.
Topics: Adult; Aged; Carcinoma, Neuroendocrine; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Huma | 2014 |
PET/Computed Tomography in Neuroendocrine Tumor: Value to Patient Management and Survival Outcomes.
Topics: Adrenal Gland Neoplasms; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Gallium Radioisotopes; Gast | 2015 |
Detection rate of recurrent medullary thyroid carcinoma using fluorine-18 dihydroxyphenylalanine positron emission tomography: a meta-analysis.
Topics: Carcinoma, Neuroendocrine; Dihydroxyphenylalanine; Humans; Neoplasm Recurrence, Local; Positron-Emis | 2012 |
Comparison of different positron emission tomography tracers in patients with recurrent medullary thyroid carcinoma: our experience and a review of the literature.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Neuroendocrine; Dihydroxyphenylalanine; Female; Fluorodeo | 2013 |
6-L-18F-fluorodihydroxyphenylalanine PET in neuroendocrine tumors: basic aspects and emerging clinical applications.
Topics: Adenoma, Islet Cell; Dihydroxyphenylalanine; Humans; Hyperinsulinism; Neuroendocrine Tumors; Pancrea | 2008 |
2 trials available for dihydroxyphenylalanine and Cancer of the Thyroid
Article | Year |
---|---|
Complementary roles of 18F-DOPA PET/CT and 18F-FDG PET/CT in medullary thyroid cancer.
Topics: Adult; Aged; Calcitonin; Carcinoembryonic Antigen; Carcinoma, Neuroendocrine; Cell Proliferation; Di | 2011 |
18F-DOPA positron emission tomography for tumour detection in patients with medullary thyroid carcinoma and elevated calcitonin levels.
Topics: Aged; Calcitonin; Carcinoma, Medullary; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Huma | 2001 |
25 other studies available for dihydroxyphenylalanine and Cancer of the Thyroid
Article | Year |
---|---|
Synchronous bilateral pheochromocytomas and bilobar medullary thyroid carcinoma revealed by
Topics: Adrenal Gland Neoplasms; Adult; Carcinoma, Neuroendocrine; Dihydroxyphenylalanine; Female; Humans; M | 2019 |
Which Is the Optimal Scan Time of 18F-DOPA PET/CT in Patients With Recurrent Medullary Thyroid Carcinoma?: Results From a Dynamic Acquisition Study.
Topics: Carcinoma, Neuroendocrine; Dihydroxyphenylalanine; Female; Humans; Image Processing, Computer-Assist | 2020 |
The value of 18F-DOPA PET/CT in patients with medullary thyroid carcinoma and increased calcitonin values.
Topics: Adolescent; Adult; Aged; Calcitonin; Carcinoembryonic Antigen; Carcinoma, Neuroendocrine; Dihydroxyp | 2017 |
[
Topics: Adult; Aged; Carcinoma, Neuroendocrine; Dihydroxyphenylalanine; Female; Humans; Male; Middle Aged; P | 2018 |
Medullary Thyroid Carcinoma: Do Ultrasonography and F-DOPA-PET-CT Influence the Initial Surgical Strategy?
Topics: Adolescent; Adult; Aged; Calcitonin; Carcinoma, Neuroendocrine; Child; Clinical Decision-Making; Dih | 2018 |
Parathyroid Glands Hyperplasias Mimicking Medullary Thyroid Carcinoma Metastatic Lymph Nodes on 18F-DOPA PET/CT.
Topics: Adult; Carcinoma, Neuroendocrine; Diagnosis, Differential; Dihydroxyphenylalanine; Female; Fluorine | 2019 |
Relevance of calcitonin cut-off in the follow-up of medullary thyroid carcinoma for conventional imaging and 18-fluorine-fluorodihydroxyphenylalanine PET.
Topics: Adult; Aged; Aged, 80 and over; Calcitonin; Carcinoma, Medullary; Dihydroxyphenylalanine; Female; Fo | 2014 |
(18)F-DOPA PET/CT in the diagnosis and localization of persistent medullary thyroid carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Calcitonin; Carcinoma, Neuroendocrine; Dihydroxyphenylalanine; Femal | 2016 |
18F-DOPA PET/CT in Orbital Metastasis From Medullary Thyroid Carcinoma.
Topics: Adult; Calcitonin; Carcinoma, Neuroendocrine; Dihydroxyphenylalanine; Female; Fluorine Radioisotopes | 2016 |
The value of 18F-DOPA PET-CT in patients with medullary thyroid carcinoma: comparison with 18F-FDG PET-CT.
Topics: Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission | 2009 |
PET imaging of medullary thyroid carcinoma in MEN2A transgenic mice using 6-[(18)F]F-L-DOPA.
Topics: Animals; Carcinoma, Medullary; Dihydroxyphenylalanine; Mice; Mice, Transgenic; Multiple Endocrine Ne | 2010 |
(68)Ga-somatostatin analogues PET and (18)F-DOPA PET in medullary thyroid carcinoma.
Topics: Carcinoma, Medullary; Dihydroxyphenylalanine; Humans; Neoplasm Recurrence, Local; Organometallic Com | 2010 |
Dual PET/CT with (18)F-DOPA and (18)F-FDG in metastatic medullary thyroid carcinoma and rapidly increasing calcitonin levels: Comparison with conventional imaging.
Topics: Adult; Aged; Biomarkers, Tumor; Calcitonin; Carcinoma, Medullary; Chi-Square Distribution; Dihydroxy | 2010 |
Visualization of cardiac metastasis from medullary thyroid carcinoma on F-18 DOPA PET/CT scan.
Topics: Carcinoma; Dihydroxyphenylalanine; Female; Heart Neoplasms; Humans; Middle Aged; Positron-Emission T | 2010 |
Clinical value of 18-fluorine-fluorodihydroxyphenylalanine positron emission tomography/computed tomography in the follow-up of medullary thyroid carcinoma.
Topics: Adolescent; Adult; Aged; Calcitonin; Carcinoma, Medullary; Child; Dihydroxyphenylalanine; Disease Pr | 2010 |
Solitary hepatic metastasis from medullary thyroid carcinoma mimicking atypical hemangioma: insights from multimodality diagnostic approach by MRI, F-18 FDG and F-18 FDOPA PET/CT.
Topics: Diagnosis, Differential; Diagnostic Imaging; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; | 2010 |
Metabolic imaging allows early prediction of response to vandetanib.
Topics: Aged; Animals; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cyclins; Dihydroxyphenylalanine; Do | 2011 |
Comparison of 18F-DOPA, 18F-FDG and 68Ga-somatostatin analogue PET/CT in patients with recurrent medullary thyroid carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Calcitonin; Carcinoma, Neuroendocrine; Dihydroxyphenylalanine; Femal | 2012 |
Added value of early 18F-FDOPA PET/CT acquisition time in medullary thyroid cancer.
Topics: Adult; Aged; Carcinoma, Medullary; Dihydroxyphenylalanine; Female; Humans; Male; Middle Aged; Multim | 2012 |
Terminal ileum neuroendocrine incidentaloma in a patient with sporadic medullary thyroid carcinoma: findings from 18F-FDOPA PET/CT investigation.
Topics: Carcinoma, Neuroendocrine; Dihydroxyphenylalanine; Female; Humans; Ileal Neoplasms; Incidental Findi | 2012 |
Clinical relevance of 18F-FDG PET and 18F-DOPA PET in recurrent medullary thyroid carcinoma.
Topics: Adult; Aged; Carcinoembryonic Antigen; Carcinoma, Neuroendocrine; Dihydroxyphenylalanine; Disease Pr | 2012 |
(18)F-DOPA PET/CT revealed synchronous neuroendocrine tumors in two sisters with MEN2A syndrome.
Topics: Adrenal Gland Neoplasms; Adrenalectomy; Adult; Carcinoma, Medullary; Dihydroxyphenylalanine; Female; | 2013 |
Diagnostic impact of PET with 18F-FDG, 18F-DOPA and 3-O-methyl-6-[18F]fluoro-DOPA in recurrent or metastatic medullary thyroid carcinoma.
Topics: Adult; Aged; Carcinoma, Medullary; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; M | 2007 |
Dopa decarboxylase in medullary carcinoma of the thyroid.
Topics: Adrenal Gland Neoplasms; Amine Oxidase (Copper-Containing); Aromatic Amino Acid Decarboxylase Inhibi | 1973 |
[Hydroxytryptamine in human thyroid gland neoplasms developing from the C-cells].
Topics: Amyloidosis; Dihydroxyphenylalanine; Humans; Microscopy, Fluorescence; Serotonin; Thyroid Neoplasms | 1971 |